Cement companies witnessed speculative support from investors through FY23 amid hopes of a rebound. After capex announcements in the FY24 Budget, there was further interest due to expectations that government expenditure would boost earnings, besides a generic macro-recovery. Cement earnings were under pressure in FY22 and FY23 due to high raw material and fuel costs; muted demand prevented them passing on the higher cost.
Mutual funds (MFs) are betting on a turnaround in the healthcare sector to boost returns but are divided on the prospects of the information technology (IT) sector amid uncertain growth outlook. At the end of June, all of the top 20 fund houses were overweight on the healthcare sector vis--vis the sector's presence in the BSE 200 index, shows a report by Motilal Oswal Financial Services (MOFS). In the case of the IT sector, only six of the 20 fund houses had overweight positions.
Companies planning merger and acquisition (M&A) will have to disclose the extent of "complementary linkages" among them and their impact on the market. This comes under the revised reporting requirements of the Competition Commission of India (CCI). The changes will take effect on May 1. Entities may also have to provide market-facing data of the past five years with respect to their market size, the market share of the parties, and also that of the competitors, along with customers and suppliers.
The Centre has shared a set of parameters with all states and UTs to enable service providers and monitoring teams under the national COVID-19 vaccination programme to identify any fake COVID-19 vaccines so that they are not administered in the country.
When computing moved to the cloud, it brought a lot of advantages of managing data at scale. Computation of large sets of information sourced from several locations allowed experts to interpret data at scale with flexibility. Artificial intelligence (AI) played a critical role in helping understand patterns which could lead to business insights. In the new scenario, using AI in the cloud is not enough anymore.
Deepa Gahlot lists some interesting made-for-OTT hostage dramas that you can watch.
The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks.
The headline for corporate profit growth has been very encouraging in the July-September quarter (Q2) of 2023-24 (FY24), with the combined net profit of listed companies up by 38 per cent year-on-year. However, the earnings distribution has been very lopsided, with most of the growth coming from public-sector oil-marketing companies (OMCs), banks, non-bank lenders, automobile (auto) companies, and cement producers. By comparison, companies from information technology services, fast-moving consumer goods (FMCG), retail, and consumer durables were disappointed, experiencing a sharp slowdown in net sales growth and a relatively muted increase in reported net profit.
Talking to PTI, he said the development works should be implemented by protecting the lives of the people.
Overestimation of AI can lead to an excessive level of trust and the spread of disinformation. ChatGPT's replies are riddled with factual errors, hidden in eloquent, grammatically correct sentences. This leads to a hallucination of truth, explains Kumar Abishek.
The real scene stealer of Ajay-Tabu's Fury Road is Deepak 'Deadly' Dobriyal, applauds Sukanya Verma.
Keep cover letters under one page long, advises Ajay Singh, head, people services, Quess Corp.
There seems to be a barrage of age-old blunders that people tend to commit in the name of skincare, says dermatologist Dr Batul Patel, director, The Bombay Skin Clinic.
Feeling forced or creeped out is not only a red flag, but a strong sign of possible deception. Trust your gut!
The court was informed by the central government that a security review of Swamy's private house, where he would be residing after vacating the government-allotted bungalow, has been undertaken.
'With Trump, the relationship was very transactional, whereas with President Biden it is very structured.'
'India seems to be on a relatively better wicket compared to other emerging markets.'
Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.
'The coronavirus epidemic highlights the need to start thinking more actively about multilateral coordination, including, but not confined to, health emergencies and climate uncertainties,' says Rathin Roy.
A screenplay and superstar in perfect tandem, it doesn't get better than this, applauds Sukanya Verma.
Drug maker Sun Pharmaceutical Industries on Monday said it has commercially launched generic Ethyol, used in the treatment of cancer. Ethyol is the generic version of Medimmune's Ethyol amifostine injection, used for treating cancer, Sun Pharma informed the Bombay Stock Exchange, adding that the drug has an annual sales of $80 million in the US.
.jpg)
According to information available on the European Commission website, Ranbaxy Laboratories has been fined euro 10.32 million (over Rs 80 crore).
Fund managers may end up losing out on crucial information during market hours, leading to information asymmetry vis-a-vis other institutional investors such as alternative investment funds, insurance players, or foreign portfolio investors.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.
It also advised people not to rush for self-medication, blood investigation or radiological imaging like chest X-ray or CT scan without consultation of treating medical officer.
'That is how our machinery operates and sees every prisoner.'
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.
The temptation to get into businesses that are hot is perhaps too great for any politician, no matter what his public slogans are. Nehru plunged into hot sectors of his time -- engineering and iron and steel. Modi has plunged into digital payments -- the hot sector of his time, notes Debashis Basu.
Ranbaxy Laboratories Ltd on Tuesday launched its approved generic formulation of Clarithromycin immediate release tablets in the US market.
Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.
'Since the bilateral deficit is a reality -- and a worry -- we need to find a way to deal with it,' says Ravi Bhoothalingam.
Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.
The US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.
Agnipath may be an exercise to address the genuine needs of the armed forces. But overall, it betrays the tendency to use the military and paramilitary for employment generation and shaping a national character, instead of treating them as the professional services they are, notes Shyam G Menon.
The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.
The BJP ignored the principle of the Cabinet's joint responsibility and the adage of the buck stopping at the top, observes Amulya Ganguli.
Under fire in the United States for giving distorted information on the generic drugs it sold, Ranbaxy Laboratories on Tuesday said that it will file all relevant information within a month after which the legal case initiated against it by the US government will be withdrawn.
The South African government and large pharmaceutical companies are in combat mode regarding the proposed national policy on intellectual property that hopes to improve access to medicines for the poorer sections of the population.
